|XenTech is pleased to attend to the 11th BIO Europe Spring event on March in Barcelona.
It is the perfect occasion to meet you and talk about your projects in preclinical development of anti cancer drugs.
More info about this partnering conference here.
|Meet us at the Targeted Anti-Cancer Therpies Congress in Paris. We will talk about new molecular targets and innovative cancer therapeutics in the early phases of clinical development, supplemented by associated translational research and drug development methodology.
Do you want to know more about this event ? See the official program.
|Meet us at the 7th World ADC in Berlin. Lets talk about this high potential of new biopharmaceutical drugs represented by the Antibody Drug Conjugate and how preclinical studies can help you to develop and optimize them.Do you want to know more about this event ? See the official program.|
|Because the goodwill of those we serve is the foundation of our success. It is a real pleasure at this holiday time to say « Thank you! ».
We wish you lot of happiness and prosperity in 2017.
|We are proud to announce that Dr Marianna Cornet, a talented surgeon from Bicêtre Hospital who spent her research internship at XenTech this year, is one of the 20 candidates nominated to receive a prize for the best surgical research project at the Surgical Research Forum Day in Paris.
Presentations will take place at 11:30am in Les Cordeliers 15, École de Médecine Street 75006 Paris. Dr Cornet’s presentation is entitled « Modelling clinical issues by using Patient-Derived Xenografts: evaluation of partial hepatectomy on hepatoblastoma intrahepatic and distant growth. »
Do you want to know more about this event? Go to the website and check the detailed program.
| This year in Munich is the 28th @EORTC-NCI-AACR Symposium
This event brings together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in anti cancer drug development, target selection and new discoveries in molecular biology.
We will be glad to meet you there. Come and see us at Booth C1 !
Xentech is pleased to announce its participation to the prestigious American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans in April 16-20, 2016.
Visit us at booth #1053
Meet our scientists at the poster sessions.
Poster # 2923 : Functional evaluation of interferon/STAT1 pathway activation in response to genotoxic treatment.
This year, our President & Chief Scientif officer, Jean-Gabriel Judde will make a presentation about PARPi ! Come listen to him on Tuesday 19th, 3:20pm!
If you want to know more about the 2016 program, go to the AACR website.
We will attend to this 10th edition of EBCC.
Come to see us!
From February 11th to 14th, 2016 the first Patient-Derived Cancer Models: Present and Future Applications from Basic Science to the Clinic will be held in New Orleans (Louisiana, USA).
This AACR meeting is the first one to be exclusivelly dedicated to the Patient Derived Xenografts Models, our core business! Two members of our team will attend to the event and will be pleased to meet you. Come and see us!
February 8th and 9th, 2016, Xentech will attend to the World ADC conferences in Berlin.
The event highlights all aspect of Antibody Drug Conjugate drug development from discovery, preclinical, clinical and marketisation. Two members of our scientific team will attend to this 6th edition of Wordl ADC.
Come to see us!